ClinicalTrials.gg
RecruitingNCT07419451Updated Feb 19, 2026

Health Literacy and Osteoporosis Awareness

An observational study in Osteoporosis, Health Literacy Level and Awareness and Knowledge Level, sponsored by Bandırma Onyedi Eylül University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by Bandırma Onyedi Eylül University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
190
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 67 studies in Osteoporosis with a site in Turkey — 14 open to participants now, 17 under way, none of them phase 3. Osteoporosis · Turkey.

Planned enrollment
13th of 36
190 · median 107
Started
2025
with 10 others
Observational
36 of 67
10 open now
Primary completion
2026-03
later than 6 of 16 live
Registered
56th of 67
by date

Among the 67 studies in Osteoporosis with a site in Turkey, this one is the 13th largest by planned enrollment of the 36 observational ones that give a count, is one of 11 that started in 2025, is one of 36 observational ones, reaches primary completion later than 6 of the 16 other live ones, and was the 56th registered.

Osteoporosis

1,602 studies on the registry are indexed under Osteoporosis; 209 are open to participants now.

Browse Osteoporosis studies →

Open to participants now

14 of the 67 studies in Osteoporosis with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 133 Osteoporosis studies recruiting now, 77 (58%) set no upper age limit and 20 (15%) stop at 75 or younger; 9 take children under 18; 36 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 67 studies in Osteoporosis with a site in Turkey, or all of them as a file.
02

Study summary

Osteoporosis (OP) is defined as a progressive metabolic bone disease characterized by low bone mass and deterioration of the microarchitecture of bone tissue, resulting in increased bone fragility and a higher risk of fractures. Osteoporosis and related fractures constitute a significant public health problem in our increasingly aging world. It is currently estimated that more than 200 million people worldwide are affected by osteoporosis. The most important clinical outcome of osteoporosis is fragility fractures that occur as a result of low-energy trauma.

Health literacy is an important determinant of both individual and public health and is considered a fundamental component of patient-centered care. Health literacy is defined as the ability to obtain, process, and understand relevant health information in order to make appropriate health decisions, and limited health literacy is recognized as a global public health problem. Many patients have difficulty understanding their medical conditions, medications, and care instructions due to inadequate health literacy. Patients with limited health literacy often have insufficient understanding of diagnostic and treatment protocols, which poses a risk for potential misuse of healthcare services and poorer health outcomes. Low levels of health literacy are also associated with increased hospital admissions and higher mortality rates. In contrast, higher health literacy is associated with greater health knowledge and self-confidence.

Screening for the prevention of osteoporosis and related fractures can reduce fracture-associated mortality and morbidity. Such screening may be initiated by physicians through the evaluation of osteoporosis risk factors during clinical visits, or in some cases, based on patient demand, again guided by the physician's assessment of risk factors. One of the most important factors influencing patient demand is the level of osteoporosis awareness. Early diagnosis and treatment in at-risk patient groups before fractures occur can help prevent potential complications.

In recent years, numerous scientific studies have investigated levels of osteoporosis knowledge and awareness. Some of these studies have focused on specific populations, such as individuals with spinal cord injury, rheumatoid arthritis, or patients followed after osteoporotic fractures, while others have been conducted exclusively among women.

With increasing life expectancy and the growth of the elderly population, osteoporosis has become a more prominent health issue and is no longer limited to postmenopausal women, but rather represents a serious health problem affecting individuals of both sexes.

The aim of the present study is to assess health literacy and the level of osteoporosis awareness among individuals in the age group at risk for osteoporosis and to identify factors influencing these outcomes. One of the distinguishing features of our study compared to previous research is the inclusion of both sexes. Another distinguishing aspect is the emphasis on the indication for osteoporosis screening in older adults, even in the absence of obvious risk factors such as chronic disease, medication use, or a history of fractures. We hope that our study will contribute to the existing literature on osteoporosis, health literacy, and osteoporosis awareness.

Read the detailed description

Following approval from the institutional ethics committee, female patients aged 65 years and older and male patients aged 70 years and older who present to our outpatient clinic will be enrolled in the study. The study is designed as a cross-sectional study. All patients who apply to the Physical Medicine and Rehabilitation outpatient clinic and meet the inclusion criteria will be informed about the study, and those who provide written informed consent will be included. Participants' age, sex, and educational level will be recorded.

Health literacy will be assessed using the THLS-32 (Turkish Health Literacy Scale-32). The THLS-32 is a 32-item questionnaire that evaluates two domains (treatment and services; disease prevention/health promotion) and four processes (accessing health-related information, understanding health-related information, appraising health-related information, and applying/using health-related information). The Turkish validity and reliability of the Health Literacy Scale used in European countries were established in 2016, leading to the development of the THLS-32 scale. Each item is rated as very easy (1), easy (2), difficult (3), very difficult (4), or "I do not know" (5). The index score is calculated using the formula "index = (mean - 1) × (50/3)," resulting in a score range of 0-50. Cut-off values are defined as follows: 0-25 "inadequate health literacy," >25-33 "problematic/limited health literacy," >33-42 "adequate health literacy," and >42-50 "excellent health literacy." In this survey, the minimum score is 0 and the maximum score is 50. Higher scores indicate higher health literacy levels.

Osteoporosis awareness will be evaluated using the "Osteoporosis Awareness Scale," which has demonstrated Turkish validity and reliability. The final Turkish version of the Osteoporosis Awareness Scale consists of 27 items and five subscales. The 27 items are rated on a 4-point Likert scale as follows: "I know very well" (4), "I know" (3), "I know a little" (2), and "I do not know at all" (1). The total score ranges from a minimum of 27 to a maximum of 108. Although the scale has no reverse-scored items or cut-off points, higher total scores indicate greater osteoporosis awareness. The subscales include Bone Physiology (items 22-27), Preventive Behaviors (items 4, 5, 7, 8, 9, 10, and 21), Risk Factors (items 11-15), Exercise (items 1, 2, 3, and 6), and Characteristics of Osteoporosis (items 16-20).

The collected data will be analyzed using an appropriate statistical software program.

No tests, laboratory examinations, or interventions will be performed as part of this study.

No specific safety precautions are required during the implementation of the study.

Inclusion Criteria

Female patients aged 65 years and older

Male patients aged 70 years and older

Exclusion Criteria

Cognitive dysfunction

Dementia

Uncontrolled psychiatric disorders

Adjustment disorders

Intellectual disability

Statistical Analysis

The collected data will be analyzed using SPSS version 25.0 (IBM SPSS Statistics 25 software; Armonk, NY: IBM Corp.). Continuous variables will be presented as mean ± standard deviation, and categorical variables as numbers and percentages. When parametric test assumptions are met, comparisons between independent groups will be performed using the independent samples t-test and one-way analysis of variance (ANOVA). When parametric assumptions are not met, the Mann-Whitney U test and Kruskal-Wallis test will be used. Differences between categorical variables will be examined using the chi-square test. Relationships between continuous variables will be analyzed using Spearman or Pearson correlation analyses, appropriate regression models, and differences between categorical variables will be assessed using chi-square analysis. Multivariate regression analysis is planned to evaluate the relationships between variables. A p-value \< 0.05 will be considered statistically significant.

At the beginning of the study, the sample size was calculated using the G*Power 3.1.9 software. Based on reference studies, a moderate effect size of d = 0.63 was assumed, and a total sample size of at least 64 participants (32 women and 32 men) was determined.

03

Conditions studied

  • Osteoporosis
  • Health Literacy Level
  • Awareness and Knowledge Level

Browse trials for

Keywords

  • osteoporosis
  • health literacy
  • awareness
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

One of the distinguishing features of our study compared to previous research is the inclusion of both sexes. Another distinguishing aspect is the emphasis on the indication for osteoporosis screening in older adults, even in the absence of obvious risk factors such as chronic disease, medication use, or a history of fractures.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patients aged 65 years and older
  • Male patients aged 70 years and older

Exclusion criteria

Exclusion Criteria:

  • Cognitive dysfunction
  • Dementia
  • Uncontrolled psychiatric disorders
  • Adjustment disorders
  • Intellectual disability
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
190 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • 95 men and 95 women

    equal number of patients of both sexes

    Other: Patients will only fill out a questionnaire.

Interventions

  • OtherPatients will only fill out a questionnaire.

    Health literacy will be assessed using the TSOY-32 (Turkish Health Literacy Scale-32). The TSOY-32 is a 32-item questionnaire that evaluates two domains (treatment and services; disease prevention/health promotion) and four processes (accessing health-related information, understanding health-related information, appraising health-related information, and applying/using health-related information). The Turkish validity and reliability of the Health Literacy Scale used in European countries were established in 2016 by Okyay and Abacıgil, leading to the development of the TSOY-32 scale (12). Each item is rated as very easy (1), easy (2), difficult (3), very difficult (4), or "I do not know" (5). The index score is calculated using the formula "index = (mean - 1) × (50/3)," resulting in a score range of 0-50. Cut-off values are defined as follows: 0-25 "inadequate health literacy," \>25-33 "problematic/limited health literacy," \>33-42 "adequate health literacy," and \>42-50 "excellent healt

06

What researchers measure

Primary outcomes

  1. THLS-32 (Turkish Health Literacy Scale-32)

    THLS-32 (Turkish Health Literacy Scale-32) for health literacy. In this survey, the minimum score is 0 and the maximum score is 50. Higher scores indicate higher health literacy levels.

    Time frame: 6 months

  2. Osteoporosis Awareness Scale

    "Osteoporosis Awareness Scale" for osteoporosis awareness. The total score ranges from a minimum of 27 to a maximum of 108. Although the scale has no reverse-scored items or cut-off points, higher total scores indicate greater osteoporosis awareness.

    Time frame: 6 months

Secondary outcomes

  1. Relationship between age and THSL-32

    -Relationship between age and THSL-32

    Time frame: 6 months

  2. -Relationship between age and the "Osteoporosis Awareness Scale"

    -Relationship between age and the "Osteoporosis Awareness Scale"

    Time frame: 6 months

  3. -Relationship between gender and THSL-32

    Relationship between gender and THSL-32

    Time frame: 6 months

  4. -Relationship between gender and the "Osteoporosis Awareness Scale"

    -Relationship between gender and the "Osteoporosis Awareness Scale"

    Time frame: 6 months

  5. -Relationship between education level and THSL-32

    -Relationship between education level and THSL-32

    Time frame: 6 months

  6. Relationship between education level and the "Osteoporosis Awareness Scale"

    Relationship between education level and the "Osteoporosis Awareness Scale"

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Bandırma Onyedi Eylul University Faculty of Medicine
    Balıkesir, Bandırma 10200, Turkey (Türkiye)
    Recruiting
    • Ayşe Güldem Kilciler, Prof. Dr. · Contactakilciler@bandirma.edu.tr · +9 0266 717 01 17
    • Nurten Nas Kırdar, Dr. Öğr. Üyesi · Principal investigator
08

References and documents

Publications

  • Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD; Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010 Nov 23;182(17):1864-73. doi: 10.1503/cmaj.100771. Epub 2010 Oct 12. No abstract available. PubMed 20940232 ↗
  • Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992 Nov;2(6):285-9. doi: 10.1007/BF01623184. PubMed 1421796 ↗
  • Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R; National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014 Oct;25(10):2359-81. doi: 10.1007/s00198-014-2794-2. Epub 2014 Aug 15. PubMed 25182228 ↗

Related links

Individual participant data

Plan to share: No — The data analysis and results of our scientific research have not yet been completed. The final version of our study will be shared with readers by being published in an academic journal in the field of medicine. If a suitable journal deems our study suitable for publication after the peer review process, other researchers will be able to read and benefit from this publication once it is released.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2025 (actual). Primary completion is estimated for Mar 2026, 7 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 24, 2026
First posted
Feb 19, 2026
StartActual
Jul 9, 2025
Primary completionEst.
Mar 1, 2026
CompletionEst.
Mar 30, 2026
Last update
Feb 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07419451
Lead sponsor
Bandırma Onyedi Eylül University
Responsible party
Nurten NAS KIRDAR (Assistant Professor, Bandırma Onyedi Eylül University) — Principal investigator
First posted
Feb 19, 2026
Start date
Jul 9, 2025
Primary completion
Mar 1, 2026 (estimated)
Completion
Mar 30, 2026 (estimated)
Last update
Feb 19, 2026

Study contacts

Nurten NAS KIRDAR, Dr. Öğr. Üyesi
Contact
nkirdar@bandirma.edu.tr
+905415511691
Naime Meriç KONAR EROL, Associate Professor
Contact
mkonar@bandirma.edu.tr
Nurten Nas Kırdar, Dr. Öğr. Üyesi
principal investigator · Bandırma Onyedi Eylül University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion